The final, formatted version of the article will be published soon. Introduction: Wake-promoting agents (WPAs), such as solriamfetol, have emerged as effective treatment options for treating excessive ...

Abstract: Objective: Current intrapartum fetal monitoring technology is unable to provide physicians with an objective metric of fetal well-being, leading to degraded patient outcomes and increased ...